GO:2000270 negative regulation of fibroblast apoptotic process: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000270 describes any process that stops, prevents or reduces the frequency, rate or extent of fibroblast apoptotic process, a key homeostatic and pathological control point.
• Negative regulation of fibroblast apoptosis is frequently mediated by survival signaling through PI3K/AKT/mTOR, which can be modulated pharmacologically and genetically.
• TGF-beta1/SMAD3 signaling controls fibroblast survival and fibrosis by regulating pro-apoptotic and anti-apoptotic mediators, including PDCD5 and HDAC3.
• Extracellular matrix proteins such as EMILIN2 and secreted factors such as SFRP1 and IL-10 can directly influence fibroblast susceptibility to apoptosis.
• Dysregulated fibroblast apoptosis contributes to fibrotic diseases, rheumatoid arthritis, cancer stroma remodeling and impaired wound healing.
• CRISPR knockout, point mutation, knock-in and overexpression models are essential to dissect causal roles of candidate genes in fibroblast survival.
Description
Fibroblasts are the principal matrix-producing cells of connective tissue and their lifespan is tightly controlled by programmed cell death. The Gene Ontology term GO:2000270, negative regulation of fibroblast apoptotic process, refers to any process that stops, prevents or reduces the frequency, rate or extent of fibroblast apoptosis. This regulatory node is critical because excessive fibroblast apoptosis can impair tissue repair, whereas insufficient apoptosis promotes fibrosis and pathological stromal remodeling. Understanding the molecular players that restrain fibroblast apoptosis is therefore central to both developmental biology and disease research.
negative regulation of fibroblast apoptotic process At A Glance
| GO ID | GO:2000270 |
|---|---|
| GO term | negative regulation of fibroblast apoptotic process |
| Ontology | biological_process |
| Synonym | negative regulation of fibroblast apoptosis |
| Major function | Suppression of programmed cell death in fibroblasts |
| Key signaling pathways | PI3K/AKT/mTOR, TGF-beta1/SMAD3, extrinsic apoptotic pathway modulation |
| Representative regulators | PTEN, SFRP1, EMILIN2, IL-10, PDCD5, HDAC3 |
| Disease relevance | Fibrosis, rheumatoid arthritis, cancer stroma, wound healing |
What Is GO:2000270?
GO:2000270 is a biological process term defined as any process that stops, prevents or reduces the frequency, rate or extent of fibroblast apoptotic process. In practical terms, it encompasses signaling events, transcriptional programs and protein-protein interactions that raise the threshold for fibroblast cell death or actively block the apoptotic machinery in fibroblasts.
Why Is negative regulation of fibroblast apoptotic process Important in Cell Biology?
Negative regulation of fibroblast apoptosis is important because it determines whether fibroblasts persist or are eliminated in tissues. This balance influences fibrosis, cancer progression, autoimmune joint destruction and tissue repair. Manipulating this process experimentally can reveal causal mechanisms and identify therapeutic targets.
• Controls fibroblast survival versus death, affecting tissue homeostasis.
• Dysregulation contributes to fibrotic diseases such as cardiac fibrosis and epidural fibrosis.
• Modulates the tumor microenvironment by sustaining cancer-associated fibroblasts.
• Influences rheumatoid arthritis pathogenesis through fibroblast-like synoviocyte survival.
• Provides a target for anti-fibrotic and anti-cancer therapies.
• Involves crosstalk with autophagy and pyroptosis pathways.
• Can be studied using CRISPR-based genetic models.
• Serves as a paradigm for cell-type-specific apoptosis regulation.
What Happens During negative regulation of fibroblast apoptotic process?
Survival signaling through PI3K/AKT/mTOR
In simple terms: Cells receive survival signals that block the death machinery.
Activation of PI3K/AKT/mTOR signaling promotes fibroblast survival and negatively regulates apoptosis. Inhibition of this axis reduces fibroblast proliferation and increases apoptosis, as shown in triptolide-induced epidural fibrosis models. PTEN negatively regulates PKB/Akt-dependent cell survival, thereby influencing fibroblast apoptosis sensitivity.
TGF-beta1/SMAD3-mediated control of pro-apoptotic mediators
In simple terms: A growth factor pathway adjusts the levels of proteins that decide cell fate.
TGF-beta1/SMAD3 signaling regulates programmed cell death 5 (PDCD5) and HDAC3 to suppress cardiac fibrosis post-myocardial infarction, indicating that this pathway can modulate fibroblast apoptosis and survival.
Extracellular matrix and secreted factor modulation
In simple terms: The environment around the cell sends survival or death signals.
The extracellular matrix glycoprotein EMILIN2 regulates the extrinsic apoptotic pathway, affecting fibroblast susceptibility to apoptosis. Secreted factors such as SFRP1 and IL-10 can negatively modulate pyroptosis or apoptosis in fibroblast-like synoviocytes.
Crosstalk with autophagy and pyroptosis
In simple terms: Different cell death and survival programs talk to each other.
Negative regulation of PI3K/AKT/mTOR axis affects fibroblast proliferation, apoptosis and autophagy, showing that survival signaling intersects with autophagic responses. SFRP1 negatively modulates pyroptosis of fibroblast-like synoviocytes in rheumatoid arthritis, illustrating crosstalk between apoptotic and pyroptotic pathways.
Key Genes Involved in GO:2000270 negative regulation of fibroblast apoptotic process
The following genes and proteins have been experimentally linked to the regulation of fibroblast apoptosis and survival.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTEN | Negative regulator of PI3K/AKT survival signaling | Modulates fibroblast apoptosis sensitivity |
| AKT1 | Promotes cell survival downstream of PI3K | Target for modulating fibroblast apoptosis |
| MTOR | Central kinase in survival signaling | Influences fibroblast proliferation and apoptosis |
| SMAD3 | Transcription factor downstream of TGF-beta1 | Regulates PDCD5 and HDAC3 in cardiac fibrosis |
| PDCD5 | Pro-apoptotic mediator regulated by TGF-beta1/SMAD3 | Suppresses cardiac fibrosis |
| HDAC3 | Histone deacetylase involved in fibrosis | Target of PDCD5 in fibroblast apoptosis |
| SFRP1 | Secreted Wnt antagonist | Negatively modulates pyroptosis in rheumatoid arthritis synoviocytes |
| IL-10 | Anti-inflammatory cytokine | Upregulated by miR-98 downregulation, promoting apoptosis in synoviocytes |
| EMILIN2 | Extracellular matrix glycoprotein | Regulates extrinsic apoptotic pathway in fibroblasts |
| BNIP3 | Pro-apoptotic Bcl-2 family member | Involved in autophagy and radioresistance in cancer-associated fibroblasts |
| CCDC80 | Fibroblast-derived factor | Shapes gastric cancer progression via T cell dysfunction |
| FOXO1 | Transcription factor regulating apoptosis and autophagy | Circular RNA circFOXO1 from CAFs affects TNBC autophagy and radioresistance |
| MIR27A | MicroRNA targeting BNIP3 | Mediates circFOXO1 effects in TNBC |
| MIR98 | MicroRNA regulating IL-10 | Downregulation promotes apoptosis in TNF-alpha stimulated synoviocytes |
| TNF | Pro-inflammatory cytokine | Stimulates fibroblast-like synoviocytes and modulates apoptosis |
| PIK3CA | Catalytic subunit of PI3K | Upstream activator of AKT survival signaling |
| BECN1 | Autophagy regulator | Crosstalk with apoptosis in fibroblasts |
How Is negative regulation of fibroblast apoptotic process Regulated?
Negative regulation of fibroblast apoptotic process is controlled by multiple signaling inputs. The PI3K/AKT/mTOR axis is a central survival pathway; its inhibition reduces fibroblast proliferation and increases apoptosis. PTEN acts as a negative regulator of this survival pathway, thereby promoting apoptosis when active. TGF-beta1/SMAD3 signaling modulates pro-apoptotic mediators such as PDCD5 and HDAC3, influencing fibrosis and fibroblast survival. Extracellular matrix components like EMILIN2 and secreted factors such as SFRP1 and IL-10 further tune the apoptotic threshold. Autophagy and pyroptosis pathways intersect with apoptotic regulation, adding layers of control.
negative regulation of fibroblast apoptotic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTEN | Fibrosis, cancer | PTEN knockout fibroblasts |
| SMAD3 | Cardiac fibrosis | SMAD3 knockout or point mutant fibroblasts |
| SFRP1 | Rheumatoid arthritis | SFRP1 overexpression in synoviocytes |
| IL-10 | Rheumatoid arthritis | IL-10 knock-in or overexpression |
| EMILIN2 | Fibrosis, matrix remodeling | EMILIN2 knockout fibroblasts |
Fibrotic diseases
In cardiac fibrosis post-myocardial infarction, TGF-beta1/SMAD3 regulates PDCD5 and HDAC3 to suppress fibrosis, indicating that negative regulation of fibroblast apoptosis can be maladaptive. In epidural fibrosis, inhibition of PI3K/AKT/mTOR reduces fibroblast proliferation and promotes apoptosis, suggesting a therapeutic strategy.
Rheumatoid arthritis
Fibroblast-like synoviocytes in rheumatoid arthritis show dysregulated apoptosis. SFRP1 negatively modulates pyroptosis, and downregulation of miR-98 promotes apoptosis via IL-10 upregulation, highlighting targets for modulating synoviocyte survival.
Cancer stroma
Cancer-associated fibroblasts (CAFs) support tumor progression. CAF-derived exosomal circFOXO1 promotes autophagy and radioresistance in triple-negative breast cancer via miR-27a-3p/BNIP3, linking fibroblast survival pathways to therapy resistance. CCDC80+ fibroblasts shape gastric cancer progression by inducing CD8+ T cell dysfunction.
From negative regulation of fibroblast apoptotic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PTEN loss increase fibroblast survival? | PTEN knockout fibroblasts |
| Does SMAD3 mutation alter PDCD5 expression? | SMAD3 point-mutation knock-in |
| Does SFRP1 overexpression reduce pyroptosis? | SFRP1 overexpression in synoviocytes |
| Does IL-10 upregulation promote apoptosis? | IL-10 knock-in or overexpression |
| Does EMILIN2 regulate extrinsic apoptosis? | EMILIN2 knockout fibroblasts |
| Does circFOXO1 affect autophagy in CAFs? | circFOXO1 overexpression or knockout |
How to Study the negative regulation of fibroblast apoptotic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V/PI flow cytometry | Apoptotic and necrotic cell fractions | Quantify fibroblast apoptosis |
| Caspase-3/7 activity assay | Effector caspase activation | Confirm apoptotic commitment |
| TUNEL staining | DNA fragmentation | Detect apoptosis in tissue sections |
| Western blot | Protein expression and cleavage | Assess apoptotic markers |
| RNA-seq | Global transcript changes | Identify survival networks |
| CRISPR knockout screen | Gene essentiality for survival | Discover novel regulators |
| Immunoprecipitation | Protein-protein interactions | Validate PDCD5-HDAC3 interaction |
| Luciferase reporter assay | Promoter activity | Measure transcriptional regulation |
Apoptosis assays
Annexin V/propidium iodide staining, caspase-3/7 activity assays and TUNEL staining are used to quantify fibroblast apoptosis after genetic or pharmacological manipulation.
Western blot and immunoprecipitation
Western blotting detects cleavage of caspase-3, PARP and expression of Bcl-2 family proteins. Immunoprecipitation can reveal interactions such as PDCD5-HDAC3.
RNA sequencing and qPCR
Transcriptomic profiling identifies changes in apoptotic and survival gene networks following CRISPR knockout or overexpression.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes whose loss alters fibroblast survival under stress, revealing novel regulators of GO:2000270.
How CRISPR Can Be Used to Study GO:2000270 negative regulation of fibroblast apoptotic process
Knockout
CRISPR knockout of candidate genes such as PTEN or SMAD3 in fibroblasts can test whether they are required for negative regulation of apoptosis. PTEN knockout increases AKT survival signaling and reduces apoptosis.
Point Mutation
Introducing point mutations in genes like SMAD3 can dissect phosphorylation-dependent functions in regulating PDCD5 and fibroblast survival.
Knock-in
Knock-in of tagged or reporter alleles (e.g., IL-10) allows tracking of expression and function in synoviocytes during apoptosis.
Overexpression
Overexpression of SFRP1 or EMILIN2 can test their ability to negatively regulate pyroptosis or apoptosis in fibroblasts.
How EDITGENE Supports negative regulation of fibroblast apoptotic process Research
Researchers studying negative regulation of fibroblast apoptotic process-related genes often need to determine whether a candidate gene is causally involved in fibroblast survival or death. EDITGENE provides CRISPR-based cell model services to enable such functional studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of fibroblast apoptotic process research.
Frequently Asked Questions About negative regulation of fibroblast apoptotic process
What is negative regulation of fibroblast apoptotic process?
It is the biological process that stops, prevents or reduces the frequency, rate or extent of apoptosis in fibroblasts, corresponding to GO:2000270.
What genes are involved in negative regulation of fibroblast apoptotic process?
Key genes include PTEN, AKT1, MTOR, SMAD3, PDCD5, HDAC3, SFRP1, IL-10, EMILIN2 and BNIP3.
How does PI3K/AKT/mTOR signaling affect fibroblast apoptosis?
Activation of PI3K/AKT/mTOR promotes fibroblast survival and negatively regulates apoptosis; its inhibition increases apoptosis.
What is the role of TGF-beta1/SMAD3 in fibroblast apoptosis?
TGF-beta1/SMAD3 regulates PDCD5 and HDAC3 to suppress cardiac fibrosis, thereby modulating fibroblast survival.
How is fibroblast apoptosis studied experimentally?
Common methods include Annexin V/PI staining, caspase activity assays, TUNEL, Western blot, RNA-seq and CRISPR screens.
Which diseases involve dysregulated fibroblast apoptosis?
Fibrotic diseases, rheumatoid arthritis and cancer stroma are associated with altered fibroblast apoptosis.
Can CRISPR be used to study negative regulation of fibroblast apoptotic process?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models enable causal testing of candidate genes.
What is the GO ID for negative regulation of fibroblast apoptotic process?
The GO ID is GO:2000270.
What are synonyms for negative regulation of fibroblast apoptotic process?
The synonym is negative regulation of fibroblast apoptosis.
Why is negative regulation of fibroblast apoptosis important in cancer?
Cancer-associated fibroblasts can survive and support tumor progression; their survival pathways are linked to therapy resistance.
Conclusion
GO:2000270, negative regulation of fibroblast apoptotic process, is a critical biological process that controls fibroblast lifespan in health and disease. Its dysregulation contributes to fibrosis, autoimmune arthritis and cancer stroma remodeling. CRISPR-based models and functional assays are powerful tools to dissect the underlying mechanisms and identify therapeutic targets.
References
- 1. Weng L et al.. 2023. TGF-β1/SMAD3 Regulates Programmed Cell Death 5 That Suppresses Cardiac Fibrosis Post-Myocardial Infarction by Inhibiting HDAC3.. Circ Res 133(3):237-251 PMID: 37345556
- 2. Xun X et al.. 2025. CAFs exosomal circFOXO1 promotes TNBC autophagy and radioresistance via miR-27a-3p/BNIP3 axis.. Sci Rep 15(1):29273 PMID: 40784956
- 3. Dai J et al.. 2019. Negative regulation of PI3K/AKT/mTOR axis regulates fibroblast proliferation, apoptosis and autophagy play a vital role in triptolide-induced epidural fibrosis reduction.. Eur J Pharmacol 864:172724 PMID: 31600493
- 4. Jiang P et al.. 2022. SFRP1 Negatively Modulates Pyroptosis of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis: A Review.. Front Immunol 13:903475 PMID: 35795672
- 5. Li Z et al.. 2019. Down-regulation of microRNA-98 promoted apoptosis of TNF-α stimulated human fibroblast-like synoviocytes via up-regulating IL-10.. Gene 706:124-130 PMID: 31077735
- 6. Mongiat M et al.. 2007. Regulation of the extrinsic apoptotic pathway by the extracellular matrix glycoprotein EMILIN2.. Mol Cell Biol 27(20):7176-87 PMID: 17698584
- 7. Mo S et al.. 2026. Spatially defined danger zone shapes gastric cancer progression through CCDC80(+) fibroblast-induced CD8(+) T cell dysfunction.. Apoptosis 31(3) PMID: 41793512
- 8. Stambolic V et al.. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.. Cell 95(1):29-39 PMID: 9778245
